Elevance Health Files 8-K on Financials
Ticker: ELV · Form: 8-K · Filed: Jan 23, 2025 · CIK: 1156039
Sentiment: neutral
Topics: financial-reporting, results-of-operations
TL;DR
Elevance Health dropped its latest 8-K with financial updates. Check it out.
AI Summary
Elevance Health, Inc. filed an 8-K on January 23, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, providing an update on the company's performance. Elevance Health, formerly known as Anthem, Inc., is incorporated in Indiana and headquartered in Indianapolis.
Why It Matters
This 8-K filing provides investors with crucial updates on Elevance Health's financial performance and operational results, impacting investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any unusual risks or events.
Key Players & Entities
- Elevance Health, Inc. (company) — Registrant
- Anthem, Inc. (company) — Former name
- WELLPOINT, INC (company) — Former name
- Indiana (jurisdiction) — State of incorporation
- Indianapolis (location) — Principal executive offices
- 220 Virginia Ave (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Elevance Health, Inc.'s results of operations and financial condition, and to include financial statements and exhibits.
When was this 8-K filed?
This 8-K was filed on January 23, 2025.
What are some of the former names of Elevance Health, Inc. mentioned in the filing?
The filing mentions former names including Anthem, Inc. and WELLPOINT, INC.
Where are Elevance Health, Inc.'s principal executive offices located?
Elevance Health, Inc.'s principal executive offices are located at 220 Virginia Ave, Indianapolis, IN 46204.
In which state is Elevance Health, Inc. incorporated?
Elevance Health, Inc. is incorporated in Indiana.
Filing Stats: 1,232 words · 5 min read · ~4 pages · Grade level 15.6 · Accepted 2025-01-23 06:03:24
Key Financial Figures
- $0.01 — ch registered Common Stock, Par Value $0.01 ELV NYSE Indicate by check mark wheth
Filing Documents
- elv-20250123.htm (8-K) — 32KB
- a4q2024elvearningsrelease.htm (EX-99.1) — 564KB
- abs_rxhxrgbxcxaligneda.jpg (GRAPHIC) — 35KB
- elevancehealtha.jpg (GRAPHIC) — 15KB
- image1a.jpg (GRAPHIC) — 625KB
- imagea.jpg (GRAPHIC) — 113KB
- wlp_rxhxrgbxcxaligneda.jpg (GRAPHIC) — 27KB
- 0001156039-25-000007.txt ( ) — 1903KB
- elv-20250123.xsd (EX-101.SCH) — 2KB
- elv-20250123_def.xml (EX-101.DEF) — 14KB
- elv-20250123_lab.xml (EX-101.LAB) — 24KB
- elv-20250123_pre.xml (EX-101.PRE) — 15KB
- elv-20250123_htm.xml (XML) — 3KB
02 - Results of Operations and Financial Condition
Item 2.02 - Results of Operations and Financial Condition. On January 23, 2025, Elevance Health, Inc. issued a press release reporting its fourth quarter and full year 2024 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report and incorporated herein by reference. None of the information furnished in Item 2.02 or Exhibit 99.1 hereto shall be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Unless expressly set forth by specific reference in such filings, none of the information furnished in this report shall be incorporated by reference in any filing under the Securities Act of 1933, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Exhibit 99.1 Press Release, dated January 23, 2025 , reporting Elevance Health, Inc. financial results for the quarter ended December 31 , 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
FORWARD-LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as "expect," "feel," "believe," "will," "may," "should," "anticipate," "intend," "estimate," "project," "forecast," "plan" and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the U.S. Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent required by law, we do not update or revise any forward-looking statements to reflect events or circumstances occurring after the date hereof. These risks and uncertainties include, but are not limited to: trends in healthcare costs and utilization rates; reduced enrollment; our ability to secure and implement sufficient premium rates; the impact of large scale medical emergencies, such as public health epidemics and pandemics, and other catastrophes; the impact of new or changes in existing federal, state and internat